- Moderna (NASDAQ:MRNA) has priced its public offering of 17.6M common shares at $76.00 per share, for gross proceeds of $1.34B.
- More news on: Moderna, Inc., Healthcare stocks news, , Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
On Friday, the FDA approved Moderna Inc’s (NASDAQ:MRNA) mRESVIA (mRNA-1345), an mRNA respiratory syncytial virus (RSV) vaccine to protect adu...
2024-05-31 15:30:03 ET RBC Capital analyst issues OUTPERFORM recommendation for MRNA on May 31, 2024 01:55PM ET. The previous analyst recommendation was Outperform. MRNA was trading at $141.9 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...
2024-05-31 15:00:07 ET Luca Issi from RBC Capital issued a price target of $160.00 for MRNA on 2024-05-31 13:55:00. The adjusted price target was set to $160.00. At the time of the announcement, MRNA was trading at $141.83. The overall price target consensus is at $158.4...